Nystatin

Manufacturer
Macleods Pharmaceuticals Limited | OXALIS LABS
Effective date
2021-01-29
Label type
Human Prescription Drug Label
Version
1
Source
full-release
Hydrated at
2026-05-31 20:35:16

Label at a glance#

ProductNystatin
Active ingredientNYSTATIN
Label structure9 sections

Indications and uses

Nystatin Ointment, is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species. Nystatin Ointment is not indicated for systemic, oral, intravaginal or ophthalmic use.

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Nystatin is a polyene antifungal antibiotic drug obtained from Streptomyces nursei
Nystatin Ointment USP, for topical use only, contains 100,000 USP Nystatin Units per gram, in an ointment base of light mineral oil and white petrolatum. The structural formula is as follows:



structure.jpg
structure.jpg


Molecular Weight 926.13

Molecular Formula C47H75NO17


CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Pharmacokinetics
Nystatin is not absorbed from intact skin or mucous membrane.

Microbiology
Nystatin is an antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi, including Candida albicans, C. parapsilosis, C. tropicalis, C. guilliermondi, C. pseudotropicalis, C. krusei, Torulopsis glabrata, Tricophyton rubrum, T. mentagrophytes.

Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing concentrations of nystatin, Candida albicans does not develop resistance to nystatin.Generally, resistance to nystatin does not develop during therapy. However, other species of 47 75 17 Candida (C. tropicalis, C. guilliermondi, C. krusei, and C. stellatoides) become quite resistant on treatment with nystatin and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed.

Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Nystatin Ointment, is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species.
Nystatin Ointment is not indicated for systemic, oral, intravaginal or ophthalmic use.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Nystatin Ointment is contraindicated in patients with a history of hypersensitivity to any of their components.

PRECAUTIONS

PRECAUTIONS SECTION

General
Nystatin Ointment should not be used for the treatment of systemic, oral, intravaginal or ophthalmic infections.

If irritation or sensitization develops, treatment should be discontinued and appropriate measures taken as indicated. It is recommended that KOH smears, cultures, or other diagnostic methods be used to confirm the diagnosis of cutaneous or mucocutaneous candidiasis and to rule out infection caused by other pathogens.

INFORMATION FOR THE PATIENTS

INFORMATION FOR PATIENTS SECTION

Patients using these medications should receive the following information and instructions :

1. The patient should be instructed to use these medications as directed (including the replacement of missed doses). These medications are not for any disorder other than that for which they are prescribed.

2. Even if symptomatic relief occurs within the first few days of treatment, the patient should be advised not to interrupt or discontinue therapy until the prescribed course of treatment is completed.

3. If symptoms of irritation develop, the patient should be advised to notify the physician promptly.

Laboratory Tests

LABORATORY TESTS SECTION

If there is a lack of therapeutic response, KOH smears, cultures, or other diagnostic methods should be repeated.

Carcinogenisis, Mutagenisis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

No long-term animal studies have been performed to evaluate the carcinogenic potential of nystatin. No studies have been performed to determine the mutagenicity of nystatin or its effects on male or female fertility.

Pregnancy: Teratogenic Effects

PREGNANCY SECTION

Animal reproduction studies have not been conducted with any nystatin topical preparation. It also is not known whether these preparations can cause fetal harm when used by a pregnant woman or can affect reproductive capacity. Nystatin topical preparations should be prescribed for a pregnant woman only if the potential benefit to the mother outweighs the potential risk to the fetus.

Nursing Mothers

NURSING MOTHERS SECTION

It is not known whether nystatin is excreted in human milk. Caution should be exercised when nystatin is prescribed for a nursing woman.

Pediatric use

PEDIATRIC USE SECTION

Safety and effectiveness have been established in the pediatric population from birth to 16 years.

See DOSAGE AND ADMINISTRATION

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

The frequency of adverse events reported in patients using Nystatin Ointment preparations is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application.
(See PRECAUTIONS: General.)
To report SUSPECTED ADVERSE REACTIONS, contact Macleods Pharma USA, Inc., at 1-888-943-3210 or 1-855-926-338 or FDA at 1-800-FDA-1088 (
www.fda.gov/medwatch ).

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Nystatin Ointment
Adults and Pediatric Patients (Neonates and Older):

Apply liberally to affected areas twice daily or as indicated until healing is complete.

HOW SUPPLIED

HOW SUPPLIED SECTION

Nystatin Ointment (100,000 USP Nystatin Units per gram) is a yellowish ointment available as follows:

NDC 33342-481-15 15 gram tube
NDC 33342-481-30 30 gram tube


Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].

 

Manufactured for:
Macleods Pharma USA, Inc.

Princeton, NJ 08540


Manufacturer:
Macleods Pharmaceuticals Limited
At Oxalis Labs
Baddi, Himachal Pradesh, INDIA

Rev. 01/2021


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Nystatin Ointment (100,000 USP Nystatin Units per gram)
Pack Count: 15 g Tube
NDC 33342-481-15
nystatin-tube-15-gmnystatin-tube-15-gm
Nystatin Ointment (100,000 USP Nystatin Units per gram)
Pack Count: 15 g Carton
NDC 33342-481-15
nystatin-carton-15-gmnystatin-carton-15-gm
Nystatin Ointment (100,000 USP Nystatin Units per gram)
Pack Count: 30 g Tube
NDC 33342-481-30
nystatin-tube-30-gmnystatin-tube-30-gm
Nystatin Ointment (100,000 USP Nystatin Units per gram)
Pack Count: 30 g Carton
NDC 33342-481-30

nystatin-carton-30-gmnystatin-carton-30-gm

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
884308nystatin 100,000 UNT/GM Topical OintmentPSN1
884308nystatin 100 UNT/MG Topical OintmentSCD1
884308nystatin 100,000 UNT/GM Topical OintmentSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
NYSTATIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e29fe634-dc25-094c-c77f-5d09c3eceb3eProduct name520260107
e57b6340-9387-3f9a-7307-511c81791375Product name320221214
544f8e8d-6389-eeeb-9586-aa447c08dcc7Product name520210614
1629e00f-54fb-4a43-8306-b58442b23902Product name920200430
854ec07b-1cd7-a5db-235a-7aa24d3cf97aProduct name320180628
19b9f4c1-15e9-edcc-4c16-f01ecfb5c549Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
33342-481-15Nystatin1 in 1 CARTONOINTMENT11
33342-481-15Nystatin15 g in 1 TUBEOINTMENT151
33342-481-30Nystatin30 g in 1 TUBEOINTMENT301
33342-481-30Nystatin1 in 1 CARTONOINTMENT11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
33342-481NYSTATIN OINTMENT [MACLEODS PHARMACEUTICALS LIMITED]1Current NDC, Legacy NDC, 4 package rows20210130_fe3db8b2-9de4-4f9e-b763-8536a1e4cea8.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
33342-481-15GM - Gram33342-4814517f113-4aca-48ef-a820-03b3d501b46112021-10-08
33342-481-30GM - Gram33342-481d39ba543-8b61-4a65-8fdc-e311a219dc1d12021-10-08

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
33342-48133342-481-15, 33342-481-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
NYSTATINBDF1O1C72EACTIB
LIGHT MINERAL OILN6K5787QVPIACT
PETROLATUM4T6H12BN9UIACT

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A213826-001NYSTATINNYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A213826-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-1484e616aacf4f…
2026-08-18 06:07:402026-07A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-1431067a03dcf5…
2025-08-23 18:47 UTC2025-08A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-146a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-1403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-142680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-145bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-1479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-141e350fbaab3a…
2024-05-31 18:47 UTC2024-05A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-148072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-145c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-145d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-144b0b4de00fa7…
2022-03-09 01:35 UTC2022-03A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-1487673890dc5c…
2021-03-12 10:30 UTC2021-03A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-145aa47cf7b7d7…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-146a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-141c564ffb4f44…
2023-12-20 04:57 UTC2023-12A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-149b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-143f0d92c62455…
2023-05-13 08:27 UTC2023-05A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14053a50430f4f…
2023-01-26 05:58 UTC2023-01A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-143bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-143a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213826-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT2021-01-14a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A213826-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A213826-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A213826-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213826-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A213826-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A213826-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A213826-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A213826-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A213826-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A213826-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A213826-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A213826-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A213826-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A213826-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A213826-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A213826-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A213826-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A213826-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A213826-001AT14b0b4de00fa7…
2022-03-09 01:35 UTC2022-03A213826-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A213826-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A213826-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A213826-001AT15aa47cf7b7d7…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A213826-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A213826-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A213826-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A213826-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A213826-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A213826-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A213826-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A213826-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A213826-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A213826-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A213826-001AT1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A213826-001AT1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A213826-001AT1cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213826-001AT1a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NystatinNYSTATINMacleods Pharmaceuticals Limitedfe3db8b2-9de4-4f9e-b763-8536a1e4cea82021-01-29Adverse reactionsExact identifier
ndc (package): 33342-481-15
ndc (package): 33342-481-30
ndc (product): 33342-481
ndc11 (package): 33342048115
ndc11 (package): 33342048130
spl id: fe3db8b2-9de4-4f9e-b763-8536a1e4cea8
spl set id: fe3db8b2-9de4-4f9e-b763-8536a1e4cea8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.